www.fdanews.com/articles/114124-zymogenetics-takes-back-full-rights-to-cancer-drug-candidate

ZymoGenetics Takes Back Full Rights to Cancer Drug Candidate

January 28, 2009

ZymoGenetics has gotten back full commercial rights to its lead cancer drug in development.
Xconomy